Your browser doesn't support javascript.
loading
A blended genome and exome sequencing method captures genetic variation in an unbiased, high-quality, and cost-effective manner.
Boltz, Toni A; Chu, Benjamin B; Liao, Calwing; Sealock, Julia M; Ye, Robert; Majara, Lerato; Fu, Jack M; Service, Susan; Zhan, Lingyu; Medland, Sarah E; Chapman, Sinéad B; Rubinacci, Simone; DeFelice, Matthew; Grimsby, Jonna L; Abebe, Tamrat; Alemayehu, Melkam; Ashaba, Fred K; Atkinson, Elizabeth G; Bigdeli, Tim; Bradway, Amanda B; Brand, Harrison; Chibnik, Lori B; Fekadu, Abebaw; Gatzen, Michael; Gelaye, Bizu; Gichuru, Stella; Gildea, Marissa L; Hill, Toni C; Huang, Hailiang; Hubbard, Kalyn M; Injera, Wilfred E; James, Roxanne; Joloba, Moses; Kachulis, Christopher; Kalmbach, Phillip R; Kamulegeya, Rogers; Kigen, Gabriel; Kim, Soyeon; Koen, Nastassja; Kwobah, Edith K; Kyebuzibwa, Joseph; Lee, Seungmo; Lennon, Niall J; Lind, Penelope A; Lopera-Maya, Esteban A; Makale, Johnstone; Mangul, Serghei; McMahon, Justin; Mowlem, Pierre; Musinguzi, Henry.
Afiliação
  • Boltz TA; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Chu BB; Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Liao C; Department of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
  • Sealock JM; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Ye R; Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Majara L; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Fu JM; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Service S; Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Zhan L; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Medland SE; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Chapman SB; Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Rubinacci S; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • DeFelice M; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Grimsby JL; Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Abebe T; Department of Psychiatry and Mental Health and South African Medical Council Research Unit on Risk and Resilience in Mental Disorders, Neuroscience Institute, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
  • Alemayehu M; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Ashaba FK; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Atkinson EG; Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA, USA.
  • Bigdeli T; Department of Psychiatry, Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA, USA.
  • Bradway AB; The Collaboratory, Institute for Quantitative and Computational Biosciences, University of California Los Angeles, Los Angeles, CA, USA.
  • Brand H; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Chibnik LB; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Fekadu A; Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Gatzen M; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Gelaye B; BD2: Breakthrough Discoveries for thriving with Bipolar Disorder, Santa Monica, CA, USA.
  • Gichuru S; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Gildea ML; Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School,, Boston, MA, USA.
  • Hill TC; Center for Data Sciences, Brigham and Women's Hospital and Harvard Medical School,, Boston, MA, USA.
  • Huang H; Broad Clinical Labs (BCL), Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Hubbard KM; Broad Clinical Labs (BCL), Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Injera WE; Department of Microbiology, Immunology, and Parasitology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
  • James R; Department of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
  • Joloba M; Department of Immunology & Molecular Biology, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Kachulis C; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
  • Kalmbach PR; Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, USA.
  • Kamulegeya R; Institute for Genomics in Health, The State University of New York, Brooklyn, NY, USA.
  • Kigen G; Broad Clinical Labs (BCL), Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Kim S; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Koen N; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Kwobah EK; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Kyebuzibwa J; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
  • Lee S; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
  • Lennon NJ; Department of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
  • Lind PA; Centre for Innovative Drug Development & Therapeutic Trials for Africa, Addis Ababa University, Addis Ababa, Ethiopia.
  • Lopera-Maya EA; Broad Clinical Labs (BCL), Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Makale J; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Mangul S; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
  • McMahon J; Department of Psychiatry, Harvard Medical School and The Chester M. Pierce MD, Division of Global Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
  • Mowlem P; Department of Mental Health, Moi Teaching and Referral Hospital, Eldoret, Kenya.
  • Musinguzi H; Broad Clinical Labs (BCL), Broad Institute of MIT and Harvard, Cambridge, MA, USA.
bioRxiv ; 2024 Sep 08.
Article em En | MEDLINE | ID: mdl-39282356
ABSTRACT
We deployed the Blended Genome Exome (BGE), a DNA library blending approach that generates low pass whole genome (1-4× mean depth) and deep whole exome (30-40× mean depth) data in a single sequencing run. This technology is cost-effective, empowers most genomic discoveries possible with deep whole genome sequencing, and provides an unbiased method to capture the diversity of common SNP variation across the globe. To evaluate this new technology at scale, we applied BGE to sequence >53,000 samples from the Populations Underrepresented in Mental Illness Associations Studies (PUMAS) Project, which included participants across African, African American, and Latin American populations. We evaluated the accuracy of BGE imputed genotypes against raw genotype calls from the Illumina Global Screening Array. All PUMAS cohorts had R 2 concordance ≥95% among SNPs with MAF≥1%, and never fell below ≥90% R 2 for SNPs with MAF<1%. Furthermore, concordance rates among local ancestries within two recently admixed cohorts were consistent among SNPs with MAF≥1%, with only minor deviations in SNPs with MAF<1%. We also benchmarked the discovery capacity of BGE to access protein-coding copy number variants (CNVs) against deep whole genome data, finding that deletions and duplications spanning at least 3 exons had a positive predicted value of ~90%. Our results demonstrate BGE scalability and efficacy in capturing SNPs, indels, and CNVs in the human genome at 28% of the cost of deep whole-genome sequencing. BGE is poised to enhance access to genomic testing and empower genomic discoveries, particularly in underrepresented populations.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article